JPMORGAN CHASE & CO - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$84,363,098
-48.2%
2,217,747
+24.1%
0.01%
-50.0%
Q2 2023$162,794,102
+49.7%
1,786,982
+8.4%
0.02%
+38.5%
Q1 2023$108,730,913
+113724.6%
1,648,452
-10.8%
0.01%0.0%
Q4 2022$95,525
-99.9%
1,847,309
+96.5%
0.01%
+44.4%
Q3 2022$64,205,000
+32.2%
940,047
-12.5%
0.01%
+28.6%
Q2 2022$48,564,000
-24.5%
1,073,965
-15.2%
0.01%
-12.5%
Q1 2022$64,337,000
-14.3%
1,266,238
-20.3%
0.01%
-11.1%
Q4 2021$75,075,000
+48.6%
1,587,878
+3.6%
0.01%
+50.0%
Q3 2021$50,532,000
+92.6%
1,533,142
+269.3%
0.01%
+100.0%
Q2 2021$26,233,000
+40.1%
415,093
-4.9%
0.00%
+50.0%
Q1 2021$18,721,000
-48.2%
436,280
-30.9%
0.00%
-60.0%
Q4 2020$36,130,000
+77.8%
631,632
-10.2%
0.01%
+66.7%
Q3 2020$20,322,000
+515.1%
703,405
+595.5%
0.00%
+200.0%
Q2 2020$3,304,000
+60.5%
101,139
+31.6%
0.00%
Q1 2020$2,058,000
-84.3%
76,835
-82.0%
0.00%
-100.0%
Q4 2019$13,076,000
+3323.0%
427,046
+2595.0%
0.00%
Q3 2019$382,000
+17.5%
15,846
+19.4%
0.00%
Q2 2019$325,000
+89.0%
13,276
+50.7%
0.00%
Q1 2019$172,000
+41.0%
8,811
-4.5%
0.00%
Q4 2018$122,000
-18.1%
9,225
+10.3%
0.00%
Q3 2018$149,000
-87.8%
8,365
-85.0%
0.00%
Q2 2018$1,226,000
+2402.0%
55,741
+2403.0%
0.00%
Q1 2018$49,000
-3.9%
2,227
-4.6%
0.00%
Q4 2017$51,0002,3350.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders